MEPROBAMATE 200 MG TABLET

Meprobamate
$4.9340per EA
DEA Schedule CIV

Strength

200 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097097407

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MEPROBAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA040797

On Market Since

6/7/2021

Price History

1W

0.0%

1M

-1.2%

3M

+24.8%

6M

+24.8%

1Y

+24.8%

3Y

N/A

5Y

N/A

All

-1.5%

Related Drugs

Same classification

No related drugs found.